Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1993-7-2
pubmed:abstractText
T cells have been shown to express CD26, a known ectoenzyme with dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) activity in its extracellular domain. CD26 can also deliver a second costimulatory signal and contribute to T-cell activation. In an earlier study, we established CD26-transfected Jurkat T-cell lines and demonstrated that monoclonal antibody-mediated crosslinking of CD26 and CD3 induced interleukin 2 (IL-2) production. To determine the contribution of DPPIV enzymatic activity to the costimulatory activity of CD26, human CD26 cDNA was mutated so that active-site serine was replaced by alanine. The mutant CD26 antigen lacked DPPIV enzyme activity but still retained reactivity with three anti-CD26 monoclonal antibodies directed against distinct epitopes of CD26. After stimulation with a combination of anti-CD26 and anti-CD3 antibodies, wild-type CD26 (DPPIV+)-transfected Jurkat cells produced substantially more IL-2 than did mutant CD26 (DPPIV-) or CD26- control transfectants. Nevertheless, the mutant CD26-transfected cells still produced significantly more IL-2 than did CD26- control transfectants. These results suggest that DPPIV activity plays an important but not absolute role in the co-stimulatory activity of CD26 in this system. We also found that wild-type CD26 (DPPIV+) transfectants produced more IL-2 than mutant CD26 (DPPIV-)-transfected cells or CD26- control transfectants when triggered by stimuli not involving CD26, such as anti-CD3 and phorbol ester. These results suggest that the DPPIV activity of CD26 functions to augment the cellular responses of CD26-transfected Jurkat cells to external stimuli mediated by CD26 and/or the CD3/T-cell receptor complex, thus enhancing IL-2 production.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1347701, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1352530, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1358482, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1371526, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1371820, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1671716, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1680916, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1969875, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1970666, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1971293, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-1979581, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-2147918, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-2152856, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-2466591, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-2474605, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-2479677, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-2564215, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-2564857, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-2824653, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-2891539, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-3100637, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-3136396, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-3323813, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-3507689, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-3881765, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-6205075, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-962103, http://linkedlifedata.com/resource/pubmed/commentcorrection/7685106-962853
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
90
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4586-90
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:7685106-Antigens, CD3, pubmed-meshheading:7685106-Antigens, Differentiation, T-Lymphocyte, pubmed-meshheading:7685106-Base Sequence, pubmed-meshheading:7685106-Dipeptidyl Peptidase 4, pubmed-meshheading:7685106-Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, pubmed-meshheading:7685106-Epitopes, pubmed-meshheading:7685106-Humans, pubmed-meshheading:7685106-Interleukin-2, pubmed-meshheading:7685106-Lymphocyte Activation, pubmed-meshheading:7685106-Molecular Sequence Data, pubmed-meshheading:7685106-Mutagenesis, Site-Directed, pubmed-meshheading:7685106-Oligodeoxyribonucleotides, pubmed-meshheading:7685106-Structure-Activity Relationship, pubmed-meshheading:7685106-T-Lymphocytes, pubmed-meshheading:7685106-Tetradecanoylphorbol Acetate, pubmed-meshheading:7685106-Transfection, pubmed-meshheading:7685106-Tumor Cells, Cultured
pubmed:year
1993
pubmed:articleTitle
The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
pubmed:affiliation
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S.